510(k) Report

510(k) · Cleared

Cleared

SilentCloud

K221125510(k) TraditionalCleared Jan 4, 2023261-day reviewClass II21 CFR 874.3400

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aureliym GmbH · KLW Masker, Tinnitus

Cleared on Jan 4, 2023 after a 261-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 1 later device descends from it.

Decided
Jan 4, 2023
Review
261 days
Class
Class II
Product code
KLW
Recalls
None
Predicates
0

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2026: 1 descendant cleared2020202220242026
  1. This deviceK221125 SilentCloudAureliym GmbH · 2023
  2. Descendant · cites it directly · 0 of its ownK260413 Levo Gen 2 Tinnitus Therapy SystemLevo Medical Corporation · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K260413Levo Gen 2 Tinnitus Therapy SystemLevo Medical Corporation · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K221125SilentCloudAureliym GmbH2023—
+1K260413Levo Gen 2 Tinnitus Therapy SystemLevo Medical Corporation2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K221125, 2023–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KLW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KLW device

  1. #1 K260413 Levo Gen 2 Tinnitus Therapy Systemscore 11.8 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K260413Levo Gen 2 Tinnitus Therapy SystemLevo Medical Corporation20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K260413 (Levo Medical Corporation, 2026) has gone furthest, with 0 descendants of its own.

How does its category compare?

All KLW devices

KLW Masker, Tinnitus: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · KLW

1in 2024

2007: 22008: 22009: 22010: 12011: 42012: 12013: 42014: 42015: 42016: 32017: 22018: 22020: 22023: 32024: 12026 (partial year): 2
2007high 4 (2011) · low 0 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KLW

261in 2023

2011: 58 days median2013: 150 days median2014: 164 days median2015: 107 days median2016: 114 days median2023: 261 days median
2007high 261 (2023) · low 58 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KLW

No recall names KLW since 2007.

Adverse event reports per year · KLW

4in 2015

2007: 12009: 12010: 12011: 12012: 12015: 4
2007high 4 (2015) · low 0 (2008)2025

MAUDE reports naming product code KLW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—01
20082—00
20092—01
20101—01
201145801
20121—01
2013415000
2014416400
2015410704
2016311400
20172—00
20182—00
20190—00
20202—00
20210—00
20220—00
2023326100
20241—00
20250—00
20262—0—

What is it indicated for?

The SilentCloud in combination with a Tinnitus Management Program is a therapeutic software tool for the treatment of

chronic subjective tinnitus for home use.

The target population for the Universal Tinnitus Management System are adult tinnitus patients over 18 years.

The SilentCloud is intended to provide relief from the disturbance of chronic subjective tinnitus while using the device.

The SlientCloud is fitted and programmed by a qualified healthcare professional familiar with tinnitus treatment.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K221125: SilentCloud.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K221125

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026